News2020-03-17T00:27:19+00:00

Stay in the know

Discover the latest financial news and exclusive features from Laidlaw

Laidlaw Capital Markets served as Financial Advisor on the $115,000,000 Follow-On Offering for EyePoint Pharmaceuticals

The Team at Laidlaw Capital Markets is pleased to have acted as Financial Advisor on the $115,000,000 Follow-On Offering, alongside Guggenheim and Cowen. This is the third transaction Laidlaw has been a part of with [...]

February 10th, 2021|News, press release|

Laidlaw served as Co-Manager on the $115,000,000 Offering for Affimed (AFMD)

Laidlaw Capital Markets is pleased to have Co-Managed Affimed’s $115,000,000 financing alongside Jefferies, SVB Leerink, and Credit Suisse. See full Press Release on Affimed Website

January 15th, 2021|News, press release|

Ready to talk?

Discover how our informed approach will help you achieve your financial goals

Contact Us
Go to Top